Obstructive sleep apnoea (OSA)

OSA is a condition in which people breathe shallowly or stop breathing for short periods while sleeping. This can occur many times at night, leading to frequent arousals and disturbed sleep. These in turn can cause excessive daytime sleepiness, impaired concentration and hypoxaemia.

The consequences of untreated OSA include impaired daytime mental functioning, personality changes and social impairment. Importantly, it can have serious consequences on activities requiring alertness. Thus, there is up to a 12 fold increase in road traffic accidents (RTAs) in patients with OSA [1]. Sleepiness at the wheel may cause up to 20% of motorway accidents, with each fatal accident estimated to cost £1.25 million to society.

Furthermore, there is now strong and emerging evidence that OSA is an independent risk factor for coronary heart disease, hypertension and Stroke (estimated 2-4x increased risk). Moreover, there is also evidence that successful treatment of OSA can reduce diastolic blood pressure by up to 5 mmHg in trials. Over time, this might have a profound impact on cardiovascular and cerebrovascular risk, as part of a collective risk reduction strategy [2,3].

OSA is emerging as a significant public health problem, with a large and increasing demand for sleep service facilities due to the high prevalence and growing public awareness of its existence. Conservative estimates of the prevalence of OSA in middle aged men (30-65y) are between 0.3-2%, which are similar to

Type 1 diabetes mellitus [4]. The prevalence in women may be more than half that of men. The gold standard treatment is nocturnal continuous positive airway pressure (CPAP), delivered easily at home.

The diagnosis and treatment of sleep apnoea are now recognised as important national requirements endorsed by NICE and other healthcare organisations (e.g The British Thoracic Society). Thus capacity of services to accommodate an emerging healthcare requirement provides both a pressure and opportunity.


  • Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med 1999;340:847-51.
  • Lipkin DP. Sleep-disordered breathing in chronic stable heart failure. Lancet 1999;354:531-2.
  • Peppard PE, Young T, Palta M, Skatrud J. Prospective study on the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
  • Stradling JR, Crosby JH. Predictors and Prevalence of Obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax 1991;46:85-90.

For Enquiries


Email us your queries at


4th Floor 396 Fulham Road London SW10 9NH

Visiting Hospital